1. Home
  2. TIGR vs ARDX Comparison

TIGR vs ARDX Comparison

Compare TIGR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UP Fintech Holding Ltd representing fifteen

TIGR

UP Fintech Holding Ltd representing fifteen

N/A

Current Price

$3.89

Market Cap

710.4M

Sector

Finance

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$2.86

Market Cap

724.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIGR
ARDX
Founded
2014
2007
Country
Singapore
United States
Employees
N/A
489
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
710.4M
724.0M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
TIGR
ARDX
Price
$3.89
$2.86
Analyst Decision
Buy
Strong Buy
Analyst Count
11
11
Target Price
$7.71
★ $12.80
AVG Volume (30 Days)
1.6M
★ 4.7M
Earning Date
12-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
$29.26
$18.85
Revenue Next Year
N/A
$26.05
P/E Ratio
$9.77
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.76
$2.96
52 Week High
$11.35
$8.40

Technical Indicators

Market Signals
Indicator
TIGR
ARDX
Relative Strength Index (RSI) 40.73 39.51
Support Level N/A N/A
Resistance Level $5.05 $3.35
Average True Range (ATR) 0.15 0.15
MACD -0.00 0.01
Stochastic Oscillator 53.51 10.78

Price Performance

Historical Comparison
TIGR
ARDX

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: